Ubiquitous convalescent plasma: An artificial universal plasma for COVID-19 patients

OBJECTIVES AND BACKGROUND: In December 2019, the first case of COVID-19 was reported in Wuhan, China. Its causative virus, is a novel strain of RNA viruses with high mortality rate. There is no definitive treatment, but among available approaches the use of recovered patients’ plasma containing spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Sattarzadeh Bardsiri, Mahla, Kouhbananinejad, Seyedeh Mehrnaz, Vahidi, Reza, Soleimany, Saeed, Moghadari, Masoud, Derakhshani, Ali, Kashani, Bahareh, Farsinejad, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191286/
https://www.ncbi.nlm.nih.gov/pubmed/34144875
http://dx.doi.org/10.1016/j.transci.2021.103188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8191286/
https://www.ncbi.nlm.nih.gov/pubmed/34144875
http://dx.doi.org/10.1016/j.transci.2021.103188

Ejemplares similares